Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
| Published in: | Administrative Law Review |
|---|---|
| Format: | Online Article RSS Article |
| Published: |
2011
|
| Subjects: | |
| Tags: |
No Tags, Be the first to tag this record!
|
| _version_ | 1867301668734894080 |
|---|---|
| collection | WordPress RSS FRELIP Feed Integration |
| container_title | Administrative Law Review |
| description | |
| discipline_display | Law |
| discipline_facet | Law |
| format | Online Article RSS Article |
| genre | Journal Article |
| id | rss_article:65060 |
| institution | FRELIP |
| journal_source_facet | Administrative Law Review |
| publishDate | 2011 |
| publishDateSort | 2011 |
| record_format | rss_article |
| spellingShingle | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process Law General Law |
| sub_discipline_display | General |
| sub_discipline_facet | General |
| subject_display | Law General Law Law General Law |
| subject_facet | Law General Law |
| title | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process |
| title_auth | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process |
| title_full | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process |
| title_fullStr | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process |
| title_full_unstemmed | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process |
| title_short | The Illusion of Interchangeability: The Benefits and Dangers of Guidance-Plus Rulemaking in the FDA's Biosimilar Approval Process |
| title_sort | the illusion of interchangeability: the benefits and dangers of guidance-plus rulemaking in the fda's biosimilar approval process |
| topic | Law General Law |
| url | https://digitalcommons.wcl.american.edu/alr/vol63/iss3/6 |